Change in dapagliflozin trial eligibility status and prognosis among patients with acute heart failure with preserved ejection fraction
Although most patients with decompensated HFpEF met the DELIVER criteria, 41.7% of initially ineligible patients became eligible after 1 year. However, no differences were observed in the adjusted 1-year rate of all-cause mortality or cardiovascular mortality and HHFs.
Authors
- Lo-Chieh Ling (ORCID: https://orcid.org/0000-0003-4734-6191)
- Chen‐Huan Chen (ORCID: https://orcid.org/0000-0002-9262-0287)
- C. F. Chiang
- WEN‐CHUNG YU
- Wei-Ming Huang
- Hao-Min Cheng
- Hao-Chih Chang
- Shih-Hsien Sung
- Ching-Wei Lee
Institutions
- National Yang Ming Chiao Tung University (TW)
- Taipei Veterans General Hospital (TW)
- Ministry of Health and Welfare (TW)
Publication Details
- Journal
- Journal of the Chinese Medical Association
- Published
- 2026-02-03
- DOI
- https://doi.org/10.1097/jcma.0000000000001349
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00